a b c
d e f
g h i
j k l
m n o
p q r s
t u v
w x y z
|
Product |
Code |
Section |
|
Mac-1 (CD11b) |
NCL-CD11b |
Cellular Adhesion Molecules |
|
MAGE-1 |
NCL-MAGE-1 |
Tumour Markers |
|
Macrophage Marker |
NCL-MACRO |
Lymphoid Markers |
|
Macrophage Marker |
NCL-LN5 |
Lymphoid Markers |
|
Macrophage Marker |
NCL-MAC387 |
Lymphoid Markers |
|
Maspin |
NCL-MASPIN |
Oncosuppressor and Associated Proteins |
|
Mast Cell Chymase |
NCL-MCC |
Lymphoid Markers |
|
Mast Cell Tryptase |
NCL-MCTRYP-428 |
Lymphoid Markers |
|
Mast Cell Tryptase |
NCL-MCTRYP |
Lymphoid Markers |
|
Matrix Metalloproteinase 1 |
NCL-MMP1 |
Tumour Markers |
|
Matrix Metalloproteinase 3 |
NCL-MMP3 |
Tumour Markers |
|
Matrix Metalloproteinase 9 |
NCL-MMP9-439 |
Tumour Markers |
|
Matrix Metalloproteinase 9 |
NCL-MMP9 |
Tumour Markers |
|
Matrix Metalloproteinase 10 |
NCL-MMP10 |
Tumour Markers |
|
MB2 (B Cell Marker) |
NCL-MB2 |
Lymphoid Markers |
|
CD146 (MCAM) |
NCL-CD146 |
Cellular Adhesion Molecules |
|
Mcl-1 |
NCL-Mcl-1 |
Cell Cycle Associated Markers |
|
MDM2 Protein |
NCL-MDM2 |
Oncoproteins |
|
MDM2 Protein |
NCL-MDM2p |
Oncoproteins |
|
Melan A |
NCL-MelanA |
Tumour Markers |
|
Melan A (Liquid Primary Antibody) |
NCL-L-MelanA |
Tumour Markers |
|
Melan A (Ready to Use) |
RTU-MelanA |
Tumour Markers |
|
Melanoma Marker (CD63) |
NCL-CD63 |
Tumour Markers |
|
Melanoma Marker (HMB45) |
NCL-HMB45 |
Tumour Markers |
|
Merosin Laminin Alpha 2 Chain |
NCL-MEROSIN |
Muscle Disease |
|
Mesothelin |
NCL-MESO |
Tumour Markers |
|
Mesothelin (Liquid Primary Antibody) |
NCL-L-MESO |
Tumour Markers |
|
Mesothelin (Ready to Use) |
RTU-MESO |
Tumour Markers |
|
Mesothelin and Calretinin Antibodies (duo pack) |
NCL-MESO/CALRETININ |
Tumour Markers |
|
Metallothionein |
NCL-METALLO |
Tumour Markers |
|
Methicillin Resistant Staphylococcus aureus (Primer Set) |
NCL-SA-PS |
Microbiology/Virology |
|
MIC2 (CD99) |
NCL-CD99 |
Cluster Differentiation Markers |
|
Microphthalmia Transcription Factor (MITF) |
NCL-MITF |
Tumour Markers |
|
Milk Fat Globule, Human |
NCL-HMFG1 |
Tumour Markers |
|
Milk Fat Globule, Human |
NCL-HMFG2 |
Tumour Markers |
|
Minichromosome Maintenance Protein 2 |
NCL-MCM2 |
Cell Cycle Associated Markers |
|
Minichromosome Maintenance Protein 5 |
NCL-MCM5 |
Cell Cycle Associated Markers |
|
Minichromosome Maintenance Protein 7 |
NCL-MCM7 |
Cell Cycle Associated Markers |
|
Mismatch Repair Protein (MSH2) |
NCL-MSH2 |
Cell Cycle Associated Markers |
|
Mitogen-Activated Protein Kinase Kinase 4 |
NCL-MKK4 |
Cell Cycle Associated Markers |
|
Mounting medium, Novomount Permanent Slide |
NCL-MOUNT |
Secondary Detection Systems and Reagents |
|
Motility-Related Protein-1 (CD9) |
NCL-CD9 |
Cluster Differentiation Markers |
|
Mouse Ig, Peroxidase-Conjugated Goat Immunoglobulin |
NCL-GAMP |
Secondary Detection Systems and Reagents |
|
Mouse Ig, FITC-Conjugated Sheep Immunoglobulin |
NCL-SAM-FITC |
Flow Cytometry |
|
Mouse IgG, Novostain Super ABC Kit |
NCL-ABCm |
Secondary Detection Systems and Reagents |
|
Mouse IgG, VECTASTAIN® Elite ABC Kit |
PK-6102 |
Secondary Detection Systems and Reagents |
|
Muc-1 Core Glycoprotein |
NCL-MUC-1-CORE |
Tumour Markers |
|
Muc-1 Glycoprotein |
NCL-MUC-1 |
Tumour Markers |
|
Muc-2 Glycoprotein |
NCL-MUC-2 |
Tumour Markers |
|
Muc-5AC Glycoprotein |
NCL-MUC-5AC |
Tumour Markers |
|
Muc-6 Glycoprotein |
NCL-MUC-6 |
Tumour Markers |
|
Multi-Cytokeratin |
NCL-AE1/AE3 |
Intermediate Filaments: Cytokeratins |
|
Multi-Cytokeratin (Liquid Primary Antibody) |
NCL-L-AE1/AE3 |
Intermediate Filaments: Cytokeratins |
|
Multi-Cytokeratin (Ready to Use) |
RTU-AE1/AE3 |
Intermediate Filaments: Cytokeratins |
|
Multi-Cytokeratin |
NCL-CKp |
Intermediate Filaments: Cytokeratins |
|
Multi-Cytokeratin (Liquid Primary Antibody) |
NCL-L-CKp |
Intermediate Filaments: Cytokeratins |
|
Multi-Cytokeratin (Ready to Use) |
RTU-CKp |
Intermediate Filaments: Cytokeratins |
|
Multi-Cytokeratin (4/5/6/8/10/13/18) |
NCL-C11 |
Intermediate Filaments: Cytokeratins |
|
Multidrug Resistance-Associated Protein 3 |
NCL-MRP3 |
Human Cytotoxic Drug Metabolism |
|
Multidrug Resistance-Associated Protein 5 |
NCL-MRP5 |
Human Cytotoxic Drug Metabolism |
|
Muramidase (Lysozyme) |
NCL-MURAM |
Lymphoid Markers |
|
Muscle Specific Actin |
NCL-MSA |
Small and Intermediate Filaments |
|
Mycobacterium bovis-BCG (Primer Set) |
NCL-BCG-PS |
Microbiology/Virology |
|
Mycobacterium tuberculosis (Species-Specific) |
NCL-MTSS |
Microbiology/Virology |
|
Mycobacterium tuberculosis Typing (Primer Set) |
NCL-MTT-PS |
Microbiology/Virology |
|
Mycobacterium tuberculosis |
NCL-MT |
Microbiology/Virology |
|
Mycobacterium tuberculosis |
NCL-MTp |
Microbiology/Virology |
|
Mycobacterium tuberculosis (Primer Set) |
NCL-MT-PS |
Microbiology/Virology |
|
Myelin Basic Protein |
NCL-MBP |
Neural Tissue and Tumour Markers |
|
Myeloid Marker (BM1) |
NCL-BM1 |
Lymphoid Markers |
|
Myeloid Marker (BM2) |
NCL-BM2 |
Lymphoid Markers |
|
Myeloperoxidase New in 2002 |
NCL-MYELO |
Tumour Markers |
|
Myeloperoxidase |
NCL-MYELOp |
Tumour Markers |
|
Myf-3 (Rhabdomyosarcoma Marker) |
NCL-Myf-3 |
Tumour Markers |
|
Myf-4 (Rhabdomyosarcoma Marker) |
NCL-Myf-4 |
Tumour Markers |
|
MyoD1 (Rhabdomyosarcoma Marker) |
NCL-MyoD1 |
Tumour Markers |
|
Myoglobin |
NCL-MYOGLOBINp |
Tumour Markers |
|
Myosin Heavy Chain (developmental) |
NCL-MHCd |
Muscle Disease |
|
Myosin Heavy Chain (fast) |
NCL-MHCf |
Muscle Disease |
|
Myosin Heavy Chain (neonatal) |
NCL-MHCn |
Muscle Disease |
|
Myosin Heavy Chain (slow) |
NCL-MHCs |
Muscle Disease |